Trial Profile
A Phase 2 Trial Evaluating the Potential of SB-030 to Prevent Vein Graft Failure in Patients with Advanced Peripheral Vascular Disease
Status:
Planning
Phase of Trial:
Phase II
Latest Information Update: 10 Apr 2018
Price :
$35
*
At a glance
- Drugs SB 030 (Primary)
- Indications Peripheral vascular disorders
- Focus Therapeutic Use
- 10 Apr 2018 New trial record
- 02 Apr 2018 According to a Symic Bio media release, this trial is under a U.S. Investigational New Drug (IND) protocol and is planned to begin in the second half of 2018.